Sagility Limited Reports Strong Q1 FY27 Results: Revenue Surges 27.6% YoY to ₹2,024 Crore; PAT Up 73.5%

Sagility Limited (formerly known as Sagility India Limited) (NSE: SAGILITY, BSE: 544282), a leading global healthcare operations partner, has announced its unaudited consolidated financial results for the first quarter ended June 30, 2026 (Q1 FY27).

The company delivered robust top-line and bottom-line momentum, backed by strong organic expansion, 27 new client additions, and the strategic acquisition of CareSeed.

Key Financial Highlights for Q1 FY27

(All financial figures in ₹ millions, unless otherwise specified)

Revenue from Operations: Climbed 31.5% year-on-year to ₹20,242.57 million (₹2,024.26 crore) in Q1 FY27, up from ₹15,389.42 million in Q1 FY26 and ₹19,634.83 million in Q4 FY26. On a dollar basis, revenue reached US$ 207.8 million, marking a 27.6% YoY growth (15.2% growth in Constant Currency terms).

Total Income: Reached ₹20,490.36 million (inclusive of ₹247.79 million in other income), compared to ₹15,488.36 million in Q1 FY26.

Profit After Tax (PAT): Surged 73.5% year-on-year to ₹2,577.27 million (₹257.73 crore), compared to ₹1,485.59 million in Q1 FY26 and ₹2,168.11 million in the preceding quarter.

Adjusted EBITDA: Reported at ₹4,716 million (US$ 49.9 million) with an EBITDA margin of 24.0%, representing a 27.9% YoY growth.

Adjusted PAT: Stood at ₹2,697 million (US$ 28.6 million) at 13.7% of revenue, up 35.1% YoY.

Earnings Per Share (EPS): Basic and diluted EPS for the quarter stood at ₹0.56 per share (face value of ₹10 each, not annualized), reflecting a 75% YoY increase over ₹0.32 in Q1 FY26. Adjusted Basic EPS reached ₹0.58.

Total Comprehensive Income: Stood at ₹2,614.10 million for the quarter.

Expense Breakdown

Consolidated total expenses for Q1 FY27 were reported at ₹16,858.52 million, compared to ₹13,384.49 million in Q1 FY26:

Employee Benefits Expense: Formed the primary expense head at ₹12,768.89 million (vs. ₹9,872.10 million in Q1 FY26).

Depreciation and Amortization: Accounted for ₹1,280.26 million (vs. ₹1,181.88 million in Q1 FY26).

Finance Costs: Stood at ₹220.99 million (vs. ₹274.08 million in Q1 FY26).

Other Expenses: Accounted for ₹2,627.10 million (vs. ₹2,056.43 million in Q1 FY26).

Total Tax Expenses: Stood at ₹1,054.57 million (comprising current tax of ₹810.70 million and deferred tax of ₹243.87 million).

Business & Operational Highlights

New Business & Pipeline: Sagility secured $35.3 million in steady-state Annual Contract Value (ACV), driven by expansion within existing accounts and increased traction from FY26 client wins.

Client Portfolio: Added 27 new clients during Q1 FY27, expanding its active client base to 109 clients.

Strategic Acquisition: Acquired CareSeed to fortify its capabilities in healthcare quality and Medicare Advantage plans. The acquisition added differentiated analytics and Healthcare Effectiveness Data and Information Set (HEDIS) capabilities while bringing 26 new clients onboard.

Global Footprint & Workforce: As of June 30, 2026, Sagility employed 47,307 professionals across 29 delivery centers spanning 5 countries.

Industry Recognition

During the quarter, Sagility earned several key industry accolades:

Named a Major Contender in both the Healthcare Customer Experience Management (CXM) and Revenue Cycle Management (RCM) Intelligent Operations PEAK Matrix® Assessments 2026.

Recognized as a Leader in the Avasant Clinical and Care Management Business Process Transformation 2026 RadarView™.

Ranked 11th among India's 100 Best Companies to Work For 2026 by Great Place to Work® India.

Featured by ET Edge among the Best Organizations for Women.

Shares of Sagility India Limited was last trading in BSE at Rs. 41.86 as compared to the previous close of Rs. 41.32. The total number of shares traded during the day was 917975 in over 3958 trades.

The stock hit an intraday high of Rs. 41.99 and intraday low of 40.78. The net turnover during the day was Rs. 37987147.00.

Commenting on the results announcement, Ramesh Gopalan, Managing Director and Group CEO said, "Healthcare organizations are increasingly looking for partners that can combine healthcare expertise with technology, AI, and operational accountability to deliver measurable outcomes. We are seeing growing demand for outcome-oriented managed services engagements, and the early momentum behind Sagility Synchrony reinforces our belief that the future of healthcare operations lies in more integrated, intelligent operating models. Our acquisition of CareSeed further strengthens our capabilities in healthcare quality and expands our reach in the Medicare Advantage and mid-market segments."

Srinivas Mattapalli, Group Chief Financial Officer added, "We have started the year on a strong note, supported by healthy business momentum, resilient profitability and robust cash generation. Our performance reflects the strength of Sagility's healthcare-focused model, the depth of our client relationships and our strong execution across markets. With a strong balance sheet, healthy cash flows and clear strategic priorities, we remain well placed to invest in growth, strengthen our capabilities and drive sustainable long-term value for our stakeholders."

Source : Equity Bulls

Keywords

SagilityIndia INE0W2G01015 ITES Q1FY27 Q1FY2027 ResultUpdate